ArticleCommunications chemistry2025
Visible-light promoted late-stage chlorination and bromination of quinones and (hetero)arenes utilizing aqueous HCl or HBr as halogen donors.
Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Late-stage C-H chlorination and bromination of bioactive scaffolds is significant for drug discovery, as carbon-halogen bonds can effectively modulate biological activity, metabolic stability, and physicochemical profiles. Here, we develop an atom-economical, radical-mediated protocol that synthesizes high-value chlorinated or brominated quinones and (hetero)arenes. The system employs inexpensive, low-molecular-weight HCl or HBr as the halogen source, commercially available NaNO₂, and blue light irradiation, without any photocatalyst or metal catalyst. The mild reaction conditions, ready availability of reagents, excellent functional-group tolerance, high regioselectivity, and facile scalability under continuous-flow operation collectively render this approach a practical and efficient protocol for the late-stage aromatic C(sp²)-H chlorination and bromination of complex drugs and natural products. Mechanistic investigations reveal that nitrosyl halides, generated in situ by reaction of NaNO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.